Principal Investigator: Patricia A. Cleary, M.S.
he Biostatistics Center served as the data coordinating center for the
ONTT,
a randomized, distributed data entry, 15-center clinical trial
of 457 patients to evaluate the benefit of corticosteroid treatment
of optic neuritis and to investigate the relationship between
optic neuritis and multiple sclerosis. The study's structure
consisted of 15 clinical centers and three central units: Study
Headquarters, Data Coordinating Center and Visual Field Reading
Center. The trial established that intravenous methylprednisolone
sped recovery of visual function without significantly improving
long-term visual outcomes and was also associated with a reduced
incidence of symptomatic multiple sclerosis; oral prednisone not
only failed to demonstrate any benefit compared to placebo but
was further associated with an increased risk of recurrence of
optic neuritis (NEJM 326:9, 1992; and NEJM 329:24, 1993). Grant
from NEI, 1987-1993.
The ONTT has published more than 25
reports
that present the results of
the ONTT.
|